Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients

Clinical Infectious Diseases

Volumn 32, Issue 4, 2001, Pages 633-635

  de la Rosa, Rafael ^a   Pineda, Juan A ^b   Delgado, Juan ^a   Macías, Juan ^b   Morillas, Francisco ^c   Martín Sánchez, Joaquina ^c   Leal, Manuel ^a   Sánchez Quijano, Armando ^a   Lissen, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; LEISHMANIASIS, VISCERAL; MALE;

EID: 0035864513     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318708     Document Type: Article

References (15)

1. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cells counts of 200 per cubic millimeter or less
2. HIV combination therapy: Partial immune restitution. Unmasking latent cryptococcal infection
3. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
4. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV disease
5. Opportunistic infections occurring during highly active antiretroviral therapy
6. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain
7. Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain
8. Visceral leishmaniasis in HIV-positive patients: Primary infection. Impact of CD4+ T-lymphocyte counts
9. Leishmaniasis: New perspectives on an underappreciated opportunistic infection
10. Is leishmaniasis ever cured?
11. Recurrent cutaneous leishmaniasis: A role for persistent parasites
12. Effect of HAART on the natural history of AIDS-related opportunistic disorders
13. Immune reconstitution in HIV-infected subjects treated with a potent antiretroviral therapy
14. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi
15. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection